Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss

作者： Annekatrin Holzhey*1, Svenja Sonntag*2, Johannes Rendenbach1, Justus S. Ernesti1, Vinodh Kakkassery2, Salvatore Grisanti2, Fred Reinholz3, Sebastian Freidank3, Alfred Vogel3, Mahdy Ranjbar1,2 1Laboratory for Angiogenesis and Ocular Cell Transplantation,University of Lübeck, 2Department of Ophthalmology,University of Lübeck, 3Institute of Biomedical Optics,University of Lübeck

简介：

Overview

This article presents a protocol for detaching corneal endothelial cells (CEC) from Descemet’s membrane (DM) using a neodymium:YAG (Nd:YAG) laser. This method serves as an ex vivo disease model for bullous keratopathy (BK), addressing the need for early-stage disease models.

Key Study Components

Area of Science

• Ophthalmology
• Cell Biology
• Laser Surgery

Background

• Current models focus on late-stage corneal endothelial cell loss.
• New treatments like stem cells and gene therapy are emerging.
• Noninvasive techniques are becoming standard in ophthalmic procedures.
• There is a lack of models for early-stage bullous keratopathy.

Purpose of Study

• To develop a reliable ex vivo model for studying early-stage BK.
• To utilize Nd:YAG laser technology for cell detachment.
• To improve understanding of corneal endothelial cell dynamics.

Methods Used

• Freshly enucleated porcine eyes were obtained.
• Eyes were disinfected and prepared for laser application.
• Nd:YAG laser was used for photodisruption of the endothelium.
• Cells were detached from Descemet’s membrane for analysis.

Main Results

• The Nd:YAG laser effectively detached CEC from DM.
• This method provides a viable model for BK research.
• Potential for application in early-stage disease treatment studies.

Conclusions

• The protocol offers a new approach to studying corneal diseases.
• It may facilitate the development of early interventions.
• Further research is needed to explore therapeutic applications.

Frequently Asked Questions